Počet záznamov: 1
cytarabín
SYS d003561 LBL 00000nx--j22000003--45-- 005 20240119200924.5 100 $a 19990101csloy0103----ba0 152 $b mesh 250 $a cytarabín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 1966 $8 eng 330 1-
$a A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) $8 eng 450 $a Ara-C $5 e $8 eng 450 $a Arabinofuranosylcytosine $5 e $8 eng 450 $a Arabinosylcytosine $5 e $8 eng 450 $a Cytosine Arabinoside $5 e $8 eng 550 $3 sllk_un_auth*d000077209 $Y Decitabine $5 B $a decitabín 550 $3 sllk_un_auth*d000964 $Y Antimetabolites, Antineoplastic $5 P $a antimetabolity protinádorové 550 $3 sllk_un_auth*d000998 $Y Antiviral Agents $5 P $a antivirotiká 550 $3 sllk_un_auth*d007166 $Y Immunosuppressive Agents $5 P $a imunosupresíva 550 $3 sllk_un_auth*d000077209 $Y Decitabine $5 F $a decitabín 686 $a D03.383.742.680.245.453 686 $a D13.570.065.300 686 $a D13.570.685.245.453 750 $a Cytarabine $8 eng 801 -0
$a US $b DNLM $c 19990101 801 -2
$a SK $b BA006 $c 20070706 801 -2
$a SK $b BA006 $c 20190426 980 $x M
Počet záznamov: 1